Anastrozole Supplier-Buyer Network — Trade Flow Analysis

Name: Anastrozole Supplier-Buyer Trade Network Dataset — 158+ Indian Exporters, 18+ Importers, 99+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Anastrozole supplier network, Anastrozole buyers, pharmaceutical export India, Anastrozole trade data

TransData Nexus

Anastrozole

India Pharmaceutical Trade Intelligence

$110.7M158 Suppliers99 CountriesHS 30049099

ExportsIndia → UNITED STATES92.3%India → BRAZIL1.9%

ImportsUNITED STATES → India$10.5M ISRAEL → India$2.0M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Who Supplies Anastrozole? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the first-largest Anastrozole exporter from India, with a market share of 83.6% and a total export value of $92.6M across 209 shipments. Their average shipment value of $442.8K is above the market average of $49.5K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 98.8% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES LLC — $91.4M across 207 shipments (98.8% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES LLC — $567.7K across 1 shipments (0.6% of this supplier's total exports)

• ACCORD HEALTHCARE INC. — $233.6K across 1 shipments (0.3% of this supplier's total exports)

• TO THE ORDER — $172.6K across 0 shipments (0.2% of this supplier's total exports)

• ACCORD UK — $131.7K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $442.8K is 795% above the market average of $49.5K, consistent with large-order contracts or value-added formulations.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Anastrozole exporter from India, with a market share of 2.6% and a total export value of $2.9M across 116 shipments. Their average shipment value of $25.1K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. AUROBINDO PHARMA USA INC is the dominant customer, accounting for 52.8% of this supplier's tracked business. Top customers include:

• AUROBINDO PHARMA USA INC — $1.5M across 61 shipments (52.8% of this supplier's total exports)

• AUROBINDO PHARMA USA INC — $886.7K across 35 shipments (30.5% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $244.7K across 10 shipments (8.4% of this supplier's total exports)

• AUROBINDO PHARMA USA INC — $140.5K across 6 shipments (4.8% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $101.7K across 4 shipments (3.5% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED operates with high shipment frequency (116 shipments) at a per-shipment value of $25.1K, indicating a broad distribution network with many smaller, regular orders.

3ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the third-largest Anastrozole exporter from India, with a market share of 2.3% and a total export value of $2.5M across 111 shipments. Their average shipment value of $22.9K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 82.0% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES LLC — $2.1M across 91 shipments (82.0% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES — $338.7K across 15 shipments (13.3% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES — $45.8K across 2 shipments (1.8% of this supplier's total exports)

• ZYDUS PHARMACEUTICAL — $36.9K across 2 shipments (1.5% of this supplier's total exports)

• ZYDUS PHARMACEUTICAL — $36.0K across 2 shipments (1.4% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED operates with high shipment frequency (111 shipments) at a per-shipment value of $22.9K, indicating a broad distribution network with many smaller, regular orders.

4NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is the fourth-largest Anastrozole exporter from India, with a market share of 2.1% and a total export value of $2.3M across 68 shipments. Their average shipment value of $33.7K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.

NATCO PHARMA LIMITED serves 5 named buyers in our database. BRECKENRIDGE PHARMACEUTICAL INC is the dominant customer, accounting for 57.5% of this supplier's tracked business. Top customers include:

• BRECKENRIDGE PHARMACEUTICAL INC — $1.3M across 39 shipments (57.5% of this supplier's total exports)

• XXECKXXRIDXX PHXXMAC — $429.3K across 13 shipments (18.7% of this supplier's total exports)

• LEXON UK LIMITED — $275.0K across 8 shipments (12.0% of this supplier's total exports)

• MARCAN PHARMACEUTICALS INC — $215.0K across 6 shipments (9.4% of this supplier's total exports)

• LEXON UK LIMITED — $54.1K across 2 shipments (2.4% of this supplier's total exports)

Key Insight: NATCO PHARMA LIMITED operates with high shipment frequency (68 shipments) at a per-shipment value of $33.7K, indicating a broad distribution network with many smaller, regular orders.

5JODAS EXPOIM PRIVATE LIMITED

JODAS EXPOIM PRIVATE LIMITED is the fifth-largest Anastrozole exporter from India, with a market share of 1.7% and a total export value of $1.9M across 24 shipments. Their average shipment value of $77.9K is above the market average of $49.5K, suggesting premium or bulk contract pricing.

JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. OOO JODAS EXPOIM is the dominant customer, accounting for 74.1% of this supplier's tracked business. Top customers include:

• OOO JODAS EXPOIM — $1.4M across 18 shipments (74.1% of this supplier's total exports)

• M/S. OOO JODAS EXPOI — $310.9K across 4 shipments (16.6% of this supplier's total exports)

• OOO JODAS EXPOIM — $131.6K across 2 shipments (7.0% of this supplier's total exports)

• SOFTCARE INTERNATION — $28.6K across 0 shipments (1.5% of this supplier's total exports)

• SOFTCARE INTERNATION — $13.3K across 0 shipments (0.7% of this supplier's total exports)

Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $77.9K is 58% above the market average of $49.5K, consistent with large-order contracts or value-added formulations.

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Anastrozole exporter from India, with a market share of 0.9% and a total export value of $1.0M across 70 shipments. Their average shipment value of $15.0K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $400.9K across 27 shipments (38.3% of this supplier's total exports)

• SUN FARMACEUTICA DO BRASIL LTDA — $196.5K across 13 shipments (18.8% of this supplier's total exports)

• SUN PHARMA PHILIPPIN — $178.0K across 12 shipments (17.0% of this supplier's total exports)

• SUN FARMACEUTICA DO BRASIL LTDA — $160.0K across 11 shipments (15.3% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $111.7K across 7 shipments (10.7% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (70 shipments) at a per-shipment value of $15.0K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Anastrozole imports from India, with a total trade value of $102.2M across 234 shipments — representing a 92.3% share of all Anastrozole exports. The average shipment value of $436.6K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Anastrozole importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 90.3% ($92.2M) of this market's total imports.

• EVERSANA LIFE SCIENCES SERVICES,LLC — $92.2M (90.3% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES — $3.7M (3.6% of United States's total)

• AUROBINDO PHARMA USA., INC, — $1.6M (1.6% of United States's total)

Key Insight: United States's per-shipment average of $436.6K (782% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Anastrozole imports from India.

Primary Market

Secondary Market

2Brazil

Brazil ranks as the second-largest destination for Anastrozole imports from India, with a total trade value of $2.1M across 30 shipments — representing a 1.9% share of all Anastrozole exports. The average shipment value of $70.5K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Anastrozole importers in Brazil: M/S. SUN FARMACEUTICA DO BRAZIL LTD is the largest buyer, accounting for 27.8% ($587.3K) of this market's total imports.

• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $587.3K (27.8% of Brazil's total)

• SUN FARMACEUTICA DO BRASIL LTDA RUA — $360.1K (17.0% of Brazil's total)

• SUN FARMACEUTICA DO BRAZIL LTDA — $310.4K (14.7% of Brazil's total)

Key Insight: Brazil's per-shipment average of $70.5K (43% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Anastrozole imports from India.

Primary Market

Secondary Market

3Russia

Russia ranks as the third-largest destination for Anastrozole imports from India, with a total trade value of $1.8M across 4 shipments — representing a 1.7% share of all Anastrozole exports. The average shipment value of $457.1K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Anastrozole importers in Russia: OOO JODAS EXPOIM is the largest buyer, accounting for 75.8% ($1.4M) of this market's total imports.

• OOO JODAS EXPOIM — $1.4M (75.8% of Russia's total)

Key Insight: Russia's per-shipment average of $457.1K (824% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Anastrozole imports from India.

Primary Market

Secondary Market

4Canada

Canada ranks as the fourth-largest destination for Anastrozole imports from India, with a total trade value of $1.2M across 16 shipments — representing a 1.0% share of all Anastrozole exports. The average shipment value of $72.0K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Anastrozole importers in Canada: MARCAN PHARMACEUTICALS INC is the largest buyer, accounting for 23.5% ($271.1K) of this market's total imports.

• MARCAN PHARMACEUTICALS INC — $271.1K (23.5% of Canada's total)

• ACCORD HEALTHCARE INC. — $259.5K (22.5% of Canada's total)

Key Insight: Canada's per-shipment average of $72.0K (46% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Anastrozole imports from India.

Primary Market

Secondary Market

5United Kingdom

United Kingdom ranks as the fifth-largest destination for Anastrozole imports from India, with a total trade value of $773.5K across 23 shipments — representing a 0.7% share of all Anastrozole exports. The average shipment value of $33.6K is below the global average of $49.5K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Anastrozole importers in United Kingdom: LEXON UK LIMITED is the largest buyer, accounting for 35.5% ($275.0K) of this market's total imports.

• LEXON UK LIMITED — $275.0K (35.5% of United Kingdom's total)

• ACCORD UK — $246.6K (31.9% of United Kingdom's total)

Key Insight: United Kingdom receives frequent, smaller shipments of Anastrozole — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

United Kingdom is a key market for Anastrozole imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Anastrozole.
2.Flow Mapping: 158 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,238 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 99 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,238 Verified Shipments

158 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Anastrozole

Anastrozole

Who Supplies Anastrozole? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Anastrozole — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Anastrozole? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Anastrozole Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INTAS PHARMACEUTICALS LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3ZYDUS LIFESCIENCES LIMITED

4NATCO PHARMA LIMITED

5JODAS EXPOIM PRIVATE LIMITED

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

From Indian Factories to Global Pharmacies — How Anastrozole Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Anastrozole Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Brazil

3Russia

4Canada

5United Kingdom

People Also Ask — Anastrozole Supplier & Trade Network

Anastrozole Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology